Melatonin is one of the most asked-about supplements in psychiatric care. It is sold over the counter, often described as a "natural" sleep aid, and frequently used by people with schizophrenia who want to sleep better without adding another psychiatric medication. The reality is more nuanced. Melatonin is genuinely useful for some sleep problems, less useful for others, and the dose and timing matter more than most users realise.
Melatonin is a hormone that signals night-time to the body clock; in schizophrenia, low doses (0.3–3 mg) taken several hours before desired bedtime can help with circadian-driven sleep timing problems and modestly with sleep onset, with a generally favourable safety profile.
What melatonin is
Melatonin is a hormone secreted by the pineal gland in response to darkness. It tells the body and brain that it is night and helps consolidate sleep. Endogenous melatonin secretion typically begins about two hours before habitual bedtime and peaks in the middle of the night. Bright light suppresses it. Supplemental melatonin mimics the natural signal but in a less precise way.
What it does well
- Shifting circadian rhythms. Low-dose melatonin taken several hours before desired bedtime can advance the body clock — useful for delayed sleep phase, jet lag, and shift-work-related rhythm problems.
- Reducing sleep latency. Modest benefit in helping people fall asleep faster, particularly older adults whose endogenous melatonin has declined.
- Total sleep time. Small improvements in some studies; not a strong hypnotic.
What it does not do well
- It does not reliably help with sleep maintenance — staying asleep through the night.
- It is not a sedative in the way benzodiazepines or trazodone are. It nudges the clock; it does not knock you out.
- It is unlikely to help insomnia driven by active psychotic symptoms, severe anxiety, or untreated sleep apnea.
Dose: less is often more
One of the most common mistakes is taking too much. Studies in healthy adults and older insomniacs suggest that doses as low as 0.3 mg may be as effective as doses 10 to 30 times higher, with fewer next-day effects. Most over-the-counter products contain 3 to 10 mg, and analyses by ConsumerLab and others have shown actual content can vary widely from the label.
A reasonable starting approach for an adult with schizophrenia and circadian-driven insomnia, in consultation with a prescriber:
- Start with 0.5–1 mg
- Take it 2–3 hours before desired bedtime for circadian phase advance, or 30–60 minutes before bedtime for a sleep-onset effect
- Adjust slowly, not exceeding 3–5 mg without specific guidance
Timing matters more than dose
Melatonin's effect on the body clock depends on when it is taken. Taken in the early evening, it advances the clock (makes you sleepy earlier). Taken in the morning, it can do the opposite. People with schizophrenia who already have a shifted clock can benefit substantially from precise timing — see circadian rhythm disruption in schizophrenia.
Safety
Melatonin has a generally favourable safety profile in adults. Common side effects include:
- Daytime grogginess, especially with high doses
- Vivid dreams
- Headache
- Mild dizziness
Serious adverse events are rare. The NCCIH overview summarises current evidence on safety and use.
Interactions to know
- Fluvoxamine — a strong CYP1A2 inhibitor — can substantially raise melatonin levels. Use cautiously and consider lower doses if your prescriber starts fluvoxamine.
- Smoking induces CYP1A2 and lowers melatonin levels. Quitting can effectively raise melatonin exposure.
- Caffeine can blunt melatonin effects.
- Antihypertensives, antidepressants, and benzodiazepines — usually mild interactions, but worth mentioning to your prescriber.
Quality control
Because melatonin is sold as a supplement in the US, content and purity vary. Look for products with USP Verified or NSF certification, which provide some assurance that the labelled dose matches what is in the bottle.
Special considerations in schizophrenia
Some people with schizophrenia have altered endogenous melatonin secretion — both timing and amplitude. A few small studies have explored melatonin as adjunctive treatment for negative symptoms, metabolic side effects, and tardive dyskinesia, with mixed and modest results. The strongest case for melatonin in schizophrenia remains targeted use for sleep timing and onset, not as a primary treatment for psychotic symptoms.
You are pregnant, breastfeeding, or take blood thinners, antidepressants that affect serotonin (the combination is generally safe but worth flagging), or strong CYP1A2 modulators like fluvoxamine. Children and adolescents should not start melatonin without paediatric guidance.
Practical use
- Pair melatonin with sleep hygiene basics — consistent wake time, morning light, evening dimming.
- Give it a fair trial — at least 2 to 4 weeks at a consistent dose and timing.
- Track sleep with a diary or wearable to see whether it is actually helping.
- If it is not helping after a fair trial, do not keep escalating the dose. Talk to your prescriber about other options.
Bottom line
Melatonin is a useful, low-risk tool for circadian-driven sleep timing problems in schizophrenia. Used at low doses with attention to timing, it can be a quiet helper. Used carelessly at high doses, it is mostly an expensive way to feel groggy in the morning. As with any sleep intervention, the foundations of light, structure, and consistency matter more than any single supplement.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.